Sinomenine (SIN) is an isoquinoline alkaloid constituent occurring in Sinomenium acutum Rehd. et Wils. and other medicinal plants. An increasing number of preclinical and clinical studies demonstrate that oral sinomenine is effective against rheumatoid arthritis. 1 Recently, our group reported that SIN functions by restoring systemic IL-17-producing T-cells (Th17)/regulatory T-cells (Treg) balance by inducing the generation of intestinal Treg cells and the migration of these cells to inflamed joint and synovium. 2 This unique gut-dependent action mode of SIN led us to explore its immunomodulatory action and mechanism in more detail.
Aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, is famous for mediating the biotransformation and carcinogenic/teratogenic effects of environmental toxins (eg, TCDD, a prototypical xenobiotic ligand of AhR). With the cloning of AhR gene in the early 1990s, 3 our understandings of the function of AhR increased, but we are still lacking of studies in toxicology and pharmacology. 4 Recently, the perspective on AhR changed. It is now known that AhR exerts an important regulatory effect on the development and function of both innate and adaptive immune cells when it responds to endogenous ligands generated from the host cells, the diet, and from microbiota, [5] [6] [7] and it connects outside environmental signals to inside cellular processes with consequences for immune cell function. 8 AhR is mainly expressed in barrier tissues (eg, gut, skin, and lung) by immune cells such as lymphocytes. The gut is enriched with metabolites derived from either the diet or microflora, and some of these metabolites can function as AhR ligands, binding to AhR and consequently inducing its nuclear translocation and transcriptional activation. The gut also has a cytokine mileau resulting from cytokine production by immune cells such as dendritic cells, likely in response to gut microbiota. 9 These environmental cues instruct the differentiation programs of immune cells (such as innate lymphoid cells and T cells), promoting the secretion and function of cytokines.
Previous studies of our research group demonstrated that norisoboldine and tetrandrine, two members of the isoquinoline alkaloid family, attenuated collagen-induced arthritis through the activation of AhR, which suggested a potential relationship between SIN and AhR. 10, 11 The present study was performed to clarify the effect of SIN on the activation of AhR, and its relevance to the induction of the generation and function of intestinal Treg cells and the consequent alleviation of arthritis.
MATERIALS AND METHODS Animals
Specific pathogen-free, eight-week-old male DBA/1J mice were purchased from B&K Universal Group Limited (Shanghai, China). They were maintained at a constant temperature and humidity, with a 12 h light-dark cycle. Water and a nutritionally adequate diet were provided ad libitum. All mice were observed daily for general health and clinical signs of disease. At the end of the study, mice were killed by CO 2 asphyxiation, followed by exsanguination, and tissues were collected postmortem. Animal welfare and experimental procedures were carried out in strict accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) and the related ethical regulations of China Pharmaceutical University.
Reagents SIN (purity 498%, Supplementary Figure 1 ) was purchased from Nanjing Zelang Pharmaceutical Technology (Nanjing, China). Leflunomide (LEF) was purchased from Suzhou Changzheng Xinkai Pharmaceutical (Suzhou, China); 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased from AccuStandard (New Haven, CT, USA); actinomycin D (Act-D) was purchased from Zhejiang Hisun Pharmaceutical (Hangzhou, China). TGF-β, IL-6, IL-2, anti-CD3/CD28 were purchased from BD Biosciences (Franklin Lakes, NJ, USA). Complete Freund's adjuvant (CFA), incomplete Freund's adjuvant (IFA), chicken type II collagen (CII), α-naphthoflavone (α-NF), resveratrol (RES), and cycloheximide (CHX) were purchased from Sigma-Aldrich (St Louis, MO, USA). RPMI-1640 medium, trypsin, penicillin, and streptomycin were purchased from Gibco BRL (Grand Island, NY, USA). Newborn calf serum (NCS) was purchased from PAA Laboratories GmbH (Morningside, Australia). The CD4 + CD62L
+ T cell isolation Kit II was purchased from Miltenyi Biotec (Headquarters, Germany). FITC-anti-CD4, APC-anti-CD25, PE-anti-Foxp3, APC-anti-IL-17A, PE-anti-IFN-γ, Annexin V, 7-AAD, fixation/permeabilization concentrate, and diluent solutions were purchased from eBioscience (San Diego, CA, USA). PMA/Ionomycin mixture and BFA/Monensin mixture were purchased from MultiSciences Biotech (Hangzhou, China). RNAi sequences directed against the mouse AhR gene were designed and chemically synthesized by RiboBio (Guangzhou, China). Mouse IL-1β, TNF-α, IL-6, IFN-γ, IL-4, IL-10, and IL-17A ELISA kits were purchased from Dakewe Biotech (Shenzhen, China); mouse anti-CII antibodies (IgG, IgG1, and IgG2a) were purchased from GENMED SCENTIFICS (Wilmington, USA). TRIzol reagent was purchased from Invitrogen (Carlsbad, CA, USA). HiScript Q RT SuperMix and AceQ qPCR SYBR Green Master Mix were purchased from Vazyme Biotech (Piscataway, NJ, USA). Antibodies for CYP1A1 and AhR were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The other chemicals and reagents used were of analytical grade. For the analysis of cell apoptosis, cells were stained with Annexin V and 7-AAD, and loaded on the flow cytometer. 12 Flow cytometric analysis was performed in a FACSCalibur instrument and analyzed with FlowJo software.
T-Helper

Suppression Assay
CD4
+ CD25 + Treg cells were sorted from the naive T-cells, which were stimulated under Treg differentiation conditions with or without SIN (1 mM) for 6 days (Treg-SIN and TregCtrl, respectively). Freshly isolated CD4 + CD25 − T-cells (Teff cells) were co-cultured with Treg-SIN or Treg-Ctrl cells at the indicated ratio (1:0, 10:1, 10:3, 1:1) for 3 days. The results were analyzed by CFSE cell proliferation assay using a flow cytometry.
Lymphocyte Culture and Treatments EL-4 cells (a mouse lymphoma cell line) were cultured in RPMI-1640 medium supplemented with 10% FBS. For all the in vitro experiments, equal volumes of the appropriate solvent were added to the control group. For experiments involving Act-D, α-NF, RES, and CHX, the first three chemicals were added 2 h before, whereas CHX was added 0.5 h before SIN (1 mM) treatment.
Western Blot and Co-Immunoprecipitation Assay
Western blot analysis was performed as previously described. 10 All values were expressed relative to the expression of GAPDH.
For the co-immunoprecipitation assay, cultured cells were lysed in 25 mM Tris (pH 8.0), 100 mM NaCl, 0.5% NP-40, 10 mM MgCl 2 , 10% glycerol, 1 × protease inhibitor and PhosphoSTOP on ice for 30 min, followed by homogenization with a 25-gauge needle. Cell lysates were incubated with anti-Hsp90 antibody overnight at 4°C for pull-down assays and then with 20 μl Protein A/G Plus-Agarose for another 4 h at 4°C. After washing with PBST, proteins were immuneblotted with the appropriate antibodies.
Quantitative Real-Time PCR (qPCR) For analysis of mRNA transcripts, gene specific values were normalized to the GAPDH housekeeping gene for each sample. 13 The primer sequences used were: for Foxp3, 5′-GG CCCTTCTCCAGGACAGA-3′ (sense) and 5′-GCTGATCAT GGCTGGGTTGT-3′ (antisense); for RORγt, 5′-TGTCCTGG GCTACCCTACTG-3′ (sense) and 5′-GTGCAGGAGTAGGC CACATT-3′ (antisense); for IL-10, 5′-CAAGCACCACTCCA CCTAGC-3′ (sense) and 5′-GAGAGAGACCAGTTGGCGA G-3′ (antisense); for IL-17A, 5′-CCTCAAAGCTCAGCGTGT CC-3′ (sense) and 5′-GAGCTCACTTTTGCGCCAAG-3′ (antisense); for CYP1A1, 5′-GACCTGAATGAGAAGTTCTACAG C-3′ (sense) and 5′-CGGAAGGTCTCCAGGATGAAG-3′ (antisense); for GAPDH, 5′-TTCACCACCATGGAGAAGGC-3′ (sense) and 5′-GGCATGGACTGTGGTCATGA-3′ (antisense).
Transfection
RNAi sequences directed against the mouse AhR gene were designed and chemically synthesized. We searched the genome database (BLAST, SSEARCH) to ensure that these sequences do not target other human genes. EL-4 cells were plated in culture plates and allowed to grow to~40% confluence. Transfections with siRNA were performed using lipofectamine 2000 reagent in six-well plates at~40% confluence. Three different siRNA for AhR were used for getting the optimal transfection. EL-4 cells were transfected with these siAhRs, respectively. The knock-down efficiencies were assessed by PCR 48 h after transfection. SiAhR #1 with the most optimal transfection efficiency was chosen for the subsequent experiments (Supplementary Figure 2) .
Assay of CYP1A1 Activity
The CYP1A1-dependent ethoxyresorufin-O-deethylase activity was assayed as previously described. 10 Enzymatic activity was normalized for cellular protein content according to the manufacturer's instructions.
Luciferase (Luc) Assay
Lymphocytes were transiently transfected with the XREluciferase reporter plasmid pGL3-control, pGL3basic, and pGL3-XRE-Y by incubating cells with DNA-Lipofectamine 2000 complexes. 10 After transfection, cells were incubated with indicated treatments and then lysed. The lysates were assayed for luciferase activity using the luciferase assay system (Promega, Madison, WI, USA) with a luminometer according to the manufacturer's instructions. Luciferase activities were reported as emitted light per well as a percent of normal group.
Electrophoretic Mobility Shift Assay (EMSA) Nuclear extracts from lymphocytes were prepared using a nucleoprotein extraction kit. A complementary pair of synthetic oligonucleotides containing the XRE binding site for the transformed AhR/Arnt complex (5′-GATCTGGCTC TTCTCACGCAACTCCG-3′ and 5′-GATCCGGAGTTGCGT GAGAAGAGCCA-3′) were synthesized, purified, and labeled with biotin. The nuclear extracts mixed with probe were incubated with 2 μg of poly (dI/dC) acid in binding buffer for 30 min at 4°C, resolved on a 6.5% polyacrylamide gel at 100 V for 1 h, and then transferred to a nylon membrane. For supershift assays, the nuclear extracts were incubated with AhR antibodies for 30 min at 37°C before the complexes were analyzed by EMSA. The immunoreactive bands on nylon membranes were visualized by film exposure with enhanced chemiluminescence detection reagents. 14, 15 CIA Induction and Treatment Experimental arthritis was induced according to the methodology described previously. 10 Ten-week-old male mice were immunized by intradermal injection at the base of the tail with 100 mg type II collagen (CII) in CFA on day 0, and a boosting injection of 100 mg CII dissolved in IFA on day 21. Animals were daily inspected and the number of arthritic limbs per mouse was registered. Arthritis was defined as a visible joint erythema and/or swelling of at least one joint. The clinical severity of arthritis was graded daily for each paw by two independent observers using the following scoring system: 0 point = normal; 1 point = slight erythema; 2 points = slight swelling plus erythema; 3 points = moderate swelling and erythema; 4 point = edema and erythema from the ankle to the entire leg, yielding a maximum score of 16 per mouse. Disease severity was expressed as the mean arthritis index ± s.e.m. per group of treatment.
For treatments, SIN was administered intragastrically (i.g.) at 120 mg/kg/day, LEF was administered i.g. at 2 mg/kg/day, and RES was administered i.g. at 20 mg/kg/day.
Adoptive Transfer Experiment
On day 41 after collagen immunization, CD4 + CD25 + T-cells were sorted from mouse MLNs treated with SIN (SIN-Treg) or vehicle (Model-Treg) using a magnetic bead sorting system. Thereafter, 3 × 10 6 cells were adoptively transferred into recipient mice three times after the first immunization. 16 After arthritic symptoms appeared, the arthritis index was observed and recorded for another two weeks.
Measurement of Cytokines and Anti-CII Antibodies
Serum was collected from mice with CIA and levels of cytokines (IL-1β, TNF-α, IL-6, IFN-γ, IL-4, IL-10, and IL-17A) and anti-CII antibodies (IgG, IgG1, and IgG2a) were measured using mouse ELISA kits according to the manufacturer's instructions. A standard curve was generated for each assay by including serial dilutions of a reference sample of pooled sera from arthritic mice. Relative level of cytokines and antibody units (AU) were obtained for each sample by reference to the standard curve.
Histological Assessment of Joint Inflammation and Cartilage Damage
Paws were removed and fixed overnight in 4% formaldehyde, decalcified with immunocal and embedded in paraffin. Sections (5 μm) were prepared and stained with hematoxylin-eosin for assessment of inflammation and histological damage. The sections were evaluated in relation to the presence of inflammatory infiltrates, synovial membrane hyperplasia, pannus formation, cartilage destruction, and bone erosion.
Immunostaining
Cell immunostaining was performed as previously described with minor modifications. 17 Cells were incubated with antiAhR antibody overnight at 4°C, and then incubated with a secondary antibody conjugated with Rhodamine B for 2 h. They were then incubated with DAPI. The images were obtained under a fluorescence microscope. Confocal microscopy of immunostaining was performed as previously described with a slight modification. 18 The tissues were fixed in acetone and stained using antibodies of anti-CD4, anti-CD25, and anti-Foxp3 for Treg cells. For the staining of Th17 cells, anti-CD4, and anti-IL-17 antibodies were used.
Molecular Docking
The three-dimensional structure of AhR was downloaded from the protein database (protein data bank, PDB), serial number: IP97. SIN was inserted into the active site of the structure, and the binding ability was detected.
Statistical Analysis
Data are presented as the means ± s.e.m. of three independent experiments. Comparisons between multiple groups were performed using the one-way analysis of variance and the Dunnett's test. Values of Po0.05 were considered to be statistically significant.
RESULTS
SIN Induced the Generation and Activation of Treg Cells
Naive CD4 + CD62L + T-cells, isolated from the MLNs of DBA1/J mice, were activated under Treg differentiation condition in the presence or absence of SIN. SIN markedly promoted the frequency of Treg cells (Figures 1a and b) and up-regulated the expressions of Foxp3 and IL-10, which were positively related to the activation extent of Treg cell (Figures 1c and d) . (Figures 1i and j) .
SIN Restrained the Differentiation of Th17 cells
Naive CD4 + CD62L + T-cells were isolated and activated under Th17 differentiation condition in the presence or absence of SIN, and the proportions of IL-17 + cells in CD4 + cells were analyzed by flow cytometry. The frequency of Th17 cells was markedly decreased from 12.5 to 7.88% after SIN (1 mM) treatment (Figures 2a and b) . SIN (1 mM) inhibited the expression of RORγt with an inhibitory ratio of 49.6% (Figure 2c) . Furthermore, SIN (1 mM) markedly decreased the levels of IL-17A, IL-17 F and IL-21 in the supernatants (Figures 2d-f) .
SIN Induced the Expression of CYP1A1 in Lymphocytes Dependent on AhR
Increasing evidence indicate the involvement of AhR in the differentiation and activity of Treg cells. [19] [20] [21] To examine whether AhR participates in the induction of SIN on Treg cells, the potential cytotoxicity of SIN in EL-4 cells was tested and the optimal concentrations (0.1, 0.3, and 1 mM) were used in the following studies, whereas TCDD was used as a positive control. SIN induced the expression of CYP1A1 (target gene of AhR) at protein and mRNA levels in a concentration-dependent manner, and it also markedly promoted the CYP1A1 activity (Figures 3a-c) .
To identify whether the increased CYP1A1 expression in response to SIN was a result of de novo RNA synthesis or de novo protein synthesis, EL-4 cells were pre-incubated with RNA polymerase inhibitor (Act-D) and protein synthesis inhibitor (CHX), respectively. Both Act-D and CHX almost completely abolished the SIN-induced increase of CYP1A1 expression (Figures 3d-f) , suggesting the requirement of AhR for de novo RNA synthesis and protein synthesis in EL-4 cells. A siAhR transfection assay further confirmed the important role that AhR had in SIN-induced CYP1A1 expression at protein and mRNA levels, and CYP1A1 activity (Figures 3g-i) .
SIN Acted As an AhR Ligand
We used a computer program that predicts docking targets of small molecular compounds and proteins to assess the potential association of SIN to AhR. SIN accessed to the active site, and appeared to bind to AhR through van der Waals forces and the polarity effect.
The association of AhR/Hsp90 complex was analyzed by a co-immunoprecipitation test. SIN could effectively facilitate AhR/Hsp90 complex dissociation. RES, a known AhR antagonist, largely diminished the effect of SIN (Figure 4b ). AhR nuclear translocation was observed using fluorescence microscopy. Normally, AhR protein was mainly localized in the cytoplasm of lymphocytes (control group). However, it was found almost exclusively in the nucleus after SIN or TCDD treatment (Figure 4c) . To determine the effect of SIN on binding activation, we performed an XRE reporter assay. SIN markedly enhanced XRE reporter activity in EL-4 cells (Figure 4d ). Ligand-dependent activation of the AhR/Arnt heterodimer to XRE can be monitored by incubation of nuclear proteins with the ligand in vitro, followed by EMSA. Figure 4e showed that SIN effectively promoted the binding of AhR/Arnt to XRE sequence in CYP1A1 promoter.
An AhR Antagonist Abolished the Regulatory Effect of SIN on Th17/Treg Balance in CIA Mice SIN was orally administered to CIA mice for two consecutive weeks from day 26 after the first immunization, and the CYP1A1 expression in the MLN tissues was evaluated. SIN markedly increased the protein level and mRNA expression of CYP1A1 in MLNs, and this inductive effect of SIN could be restored by RES treatment (Figure 5a ).
The frequencies of Th17 and Treg cells in the intestine tissues of CIA mice were monitored by the flow cytometry (Figures 5b-e) and immunostaining (Figures 5f and g ). SIN increased the frequency of Treg cells and decreased the frequency of Th17 cells, which was consistent with our previous findings in rat CIA. 2 Notably, the reciprocal regulatory effect of SIN on Th17 and Treg cells was almost completely reversed by RES treatment, indicating that SIN might recover Th17/Treg balance in an AhR-dependent manner. (Figure 5h) . The joints from the recipient mice that received SIN-Treg exhibited a lower degree of inflammation and cartilage damage than those that received Model-Treg (Figures 5i and j) . Moreover, SIN-Treg reduced the serum levels of IL-17 and elevated the levels of IL-10 in recipient mice (Figure 5k ). Mice that received SIN-Treg showed fewer Th17 cells and more Treg cells distribution in MLNs (Figures 5l and m) . The above results indicated that SIN strengthened the inhibitory effect of Treg cells on inflammatory arthritis.
An AhR Antagonist Counteracted SIN-Mediated Alleviation of Mouse CIA Experimental arthritis was induced in male DBA1/J mice using CII in CFA, followed by a booster injection with CII in IFA. On day 26, several arthritic symptoms appeared and the indicated treatments started. After two weeks of treatment, mice in the model group developed arthritis rapidly, showing prominent symptoms such as paw swelling, erythema, and joint rigidity. SIN (120 mg/kg) yielded a marked decrease in arthritis index and paw swelling. RES (20 mg/kg) alone (c-f) Expressions of RORγt, IL-17A, IL-17 F, and IL-21 mRNA were analyzed by qPCR. Experiments were conducted three times, and data were expressed as means ± s.e.m., n = 3. *Po0.05, **Po0.01 vs control. qPCR, quantitative real-time PCR.
showed little effect on arthritis symptoms, but it markedly antagonized the anti-arthritic effect of SIN (Figures 6a and b) . Histological analysis of inflamed hind paws showed high scores for inflammation (8.35 ± 0.49) and bone erosion score (3.90 ± 1.78) in the mice of the model group (Figures 6c  and d) . SIN, at a dose of 120 mg/kg, reduced the inflammation score and bone erosion score to 5.78 ± 0.56 and 1.90 ± 0.33, respectively. However, RES mostly reversed the ameliorative effect of SIN on the pathological changes (7.73 ± 0.21 and 2.85 ± 0.57, respectively).
In addition, SIN (120 mg/kg) markedly lowered the levels of total IgG and IgG2a in the sera, which could be largely counteracted by RES (Figure 6e ). SIN treatment resulted in a marked depression of IL-1β, TNF-α, IL-6, and IL-17 levels, but a moderate promotion of IL-10 level, which was also markedly antagonized by RES (Figures 6f and g ). 22, 23 Earlier studies of SIN were focused on its anti-inflammatory effect. 24 Recently, we investigated the immunomodulatory effect of SIN in rat CIA, an animal model of RA whose development is dependent on the participation of Th17 and Treg cells. 2 Treatment of CII-immunized rats with SIN resulted in a dose-dependent inhibition of arthritis severity through the recirculation of lymphocytes from the gut to the inflamed joint. 2 The present study was designed to investigate how SIN affects the differentiation and function of these cells. In vitro, SIN increased the differentiation of Treg cells, and decreased the differentiation of Th17 cells. Moreover, the Treg cells induced by SIN were shown to be more effective in regulation of Teff cells, which were manifested by up-regulation of a proliferation suppressive effect, increase of apoptosis induction, and inhibition of Th1 or Th17 differentiation. Treg cells were shown to play a central role in the SIN-mediated inhibition of arthritis. However, the way by which SIN participates in the induction of Treg cells remained unknown. AhR is a ligand-activated transcription factor that belongs to the bHLH-PAS protein family, and is expressed by a vast majority of cells. 25, 26 The activation of AhR has recently been proven to be important in immune regulation. 27, 28 In natural products, isoquinoline alkaloid family has been recognized as important repertoires for AhR ligand discovery. For example, berberine could activate AhR signal pathway with a low toxicological potential. 29 Either protopine or allocryptopine was able to induce the expression of CYP1A1 (downstream transcription factor of AhR) by a way associated with mild or negligible activation of AhR. 30 Other categories of alkaloid compounds, including arecoline, 31 rutacarpine, 32 and harmine, 33 also manifested activation on AhR. Thus, SIN was more than likely to induce Treg cells and consequently inhibit arthritis through the regulation of AhR.
In the present study, SIN was shown to increase CYP1A1 expression at protein and mRNA levels in a concentrationdependent manner, and markedly promote CYP1A1 activity. Moreover, the increase of CYP1A1 expression induced by SIN was dependent on de novo RNA synthesis and protein synthesis. By contrast, siAhR transfection almost entirely diminished SIN-mediated CYP1A1 induction, indicating that the induction effect of SIN was mediated by AhR. It is well known that the action of AhR involves a multi-step, ligandinduced signal transduction process. The ligand binds to AhR and triggers the AhR/Hsp90 complex dissociation. Activated AhR translocates into the nucleus, dimerizes with ARNT, binds to specific enhancer sequences (XRE), and activates the transcription of target genes. 15 In the present study, the data obtained from molecular docking showed that SIN could stably associate with AhR. Furthermore, SIN promoted the dissociation of AhR/Hsp90 complex, facilitated the nuclear translocation of AhR, and increased XRE-dependent luciferase reporter gene expression. EMSA assay demonstrated that SIN was able to facilitate the binding of AhR to XRE. These findings indicated that SIN is an AhR ligand. As several isoquinoline alkaloids can activate AhR, 10,11 further studies on the structure-activity relationship should be valuable.
In the final part of this study, an AhR antagonist was used to clarify the AhR activation effect of SIN in vivo. We noted that the immunomodulatory effect and anti-arthritic effect of SIN manifested in an AhR-dependent manner. An adoptive transfer of Treg cells from SIN-treated mice showed more obvious improvement of arthritis symptoms in recipient mice, which indicates that SIN prompted the function of Treg cells. In combination with our previous findings in rat CIA, we can conclude that Treg cells are the key effectors for amelioration of RA after SIN treatment. ) Histologic examinations of the joints from mice in each group were performed using H&E. Histologic grades were evaluated according to inflammatory cell infiltration, synovial hyperplasia and congestion, fibroustissue hyperplasia, and bone erosion and regeneration. The histological scores of all groups were summarized. (e) Sera levels of anti-CII antibodies (IgG, IgG1, and IgG2a) were measured using ELISA kits. (f) Serum levels of proinflammatory factors (IL-1β, TNF-α, and IL-6) were measured using ELISA kits. (g) Serum levels of Th1/Th2/Th17/Tregrelated cytokines (IFN-γ, IL-4, IL-17, and IL-10) were measured using ELISA kits. Resveratrol (RES) was used as an AhR antagonist. Results were means ± s.e.m., n = 8. *Po0.05, **Po0.01 vs Model; # Po0.05, ## Po0.01 vs normal. AhR, aryl hydrocarbon receptor; SIN, sinomenine; CIA, collagen-induced arthritis; H&E, hematoxylin and eosin.
In summary, we report that SIN functions as an AhR agonist, induces Treg cell generation and function, and thereby alleviates arthritis. At present, SIN is not considered as the first line of defense drug for the treatment of RA. Given our findings that this drug potentiates Treg activity, a means of site-or cellspecific delivery of this drug to Treg cells may render its benefit in the treatment of autoimmunity diseases. Such an approach would likely decrease the amount of drug required for treatment as well as improve the overall efficacy of SIN.
